Global Blood-Brain Barrier Transport Drugs Market Professional Survey Report 2017

December 2017 | 118 pages | ID: G9D188CC961EN
QYResearch

Abstracts

This report studies Blood-Brain Barrier Transport Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Cyclenium
• BioAdvance
• EIP Pharma
• Bioasis
• Immune Pharmaceuticals
• AZ Therapies
• Palobiofarma
• Bach Pharma
• BrainsGate
• CarThera
• Dainippon Sumitomo Pharma
• Fluorinov Pharma
• Fondazione Telethon
• Minoryx
• NewGen Therapeutics

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Carrier-mediated Transport
• Receptor-mediated Transport
• Absorptive-mediated Transport
• Active Efflux Transport
• Others

By Application, the market can be split into

• Alzheimer's Disease
• Epilepsy
• Parkinson's Disease
• Multiple Sclerosis
• Hunter's Syndrome
• Brain Cancer
• Others

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Blood-Brain Barrier Transport Drugs Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF BLOOD-BRAIN BARRIER TRANSPORT DRUGS

1.1 Definition and Specifications of Blood-Brain Barrier Transport Drugs
  1.1.1 Definition of Blood-Brain Barrier Transport Drugs
  1.1.2 Specifications of Blood-Brain Barrier Transport Drugs
1.2 Classification of Blood-Brain Barrier Transport Drugs
  1.2.1 Carrier-mediated Transport
  1.2.2 Receptor-mediated Transport
  1.2.3 Absorptive-mediated Transport
  1.2.4 Active Efflux Transport
  1.2.5 Others
1.3 Applications of Blood-Brain Barrier Transport Drugs
  1.3.1 Alzheimer's Disease
  1.3.2 Epilepsy
  1.3.3 Parkinson's Disease
  1.3.4 Multiple Sclerosis
  1.3.5 Hunter's Syndrome
  1.3.6 Brain Cancer
  1.3.7 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF BLOOD-BRAIN BARRIER TRANSPORT DRUGS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Blood-Brain Barrier Transport Drugs
2.3 Manufacturing Process Analysis of Blood-Brain Barrier Transport Drugs
2.4 Industry Chain Structure of Blood-Brain Barrier Transport Drugs

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF BLOOD-BRAIN BARRIER TRANSPORT DRUGS

3.1 Capacity and Commercial Production Date of Global Blood-Brain Barrier Transport Drugs Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Blood-Brain Barrier Transport Drugs Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Blood-Brain Barrier Transport Drugs Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Blood-Brain Barrier Transport Drugs Major Manufacturers in 2016

4 GLOBAL BLOOD-BRAIN BARRIER TRANSPORT DRUGS OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Blood-Brain Barrier Transport Drugs Capacity and Growth Rate Analysis
  4.2.2 2016 Blood-Brain Barrier Transport Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Blood-Brain Barrier Transport Drugs Sales and Growth Rate Analysis
  4.3.2 2016 Blood-Brain Barrier Transport Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Blood-Brain Barrier Transport Drugs Sales Price
  4.4.2 2016 Blood-Brain Barrier Transport Drugs Sales Price Analysis (Company Segment)

5 BLOOD-BRAIN BARRIER TRANSPORT DRUGS REGIONAL MARKET ANALYSIS

5.1 North America Blood-Brain Barrier Transport Drugs Market Analysis
  5.1.1 North America Blood-Brain Barrier Transport Drugs Market Overview
  5.1.2 North America 2012-2017E Blood-Brain Barrier Transport Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Blood-Brain Barrier Transport Drugs Sales Price Analysis
  5.1.4 North America 2016 Blood-Brain Barrier Transport Drugs Market Share Analysis
5.2 China Blood-Brain Barrier Transport Drugs Market Analysis
  5.2.1 China Blood-Brain Barrier Transport Drugs Market Overview
  5.2.2 China 2012-2017E Blood-Brain Barrier Transport Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Blood-Brain Barrier Transport Drugs Sales Price Analysis
  5.2.4 China 2016 Blood-Brain Barrier Transport Drugs Market Share Analysis
5.3 Europe Blood-Brain Barrier Transport Drugs Market Analysis
  5.3.1 Europe Blood-Brain Barrier Transport Drugs Market Overview
  5.3.2 Europe 2012-2017E Blood-Brain Barrier Transport Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Blood-Brain Barrier Transport Drugs Sales Price Analysis
  5.3.4 Europe 2016 Blood-Brain Barrier Transport Drugs Market Share Analysis
5.4 Southeast Asia Blood-Brain Barrier Transport Drugs Market Analysis
  5.4.1 Southeast Asia Blood-Brain Barrier Transport Drugs Market Overview
  5.4.2 Southeast Asia 2012-2017E Blood-Brain Barrier Transport Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Blood-Brain Barrier Transport Drugs Sales Price Analysis
  5.4.4 Southeast Asia 2016 Blood-Brain Barrier Transport Drugs Market Share Analysis
5.5 Japan Blood-Brain Barrier Transport Drugs Market Analysis
  5.5.1 Japan Blood-Brain Barrier Transport Drugs Market Overview
  5.5.2 Japan 2012-2017E Blood-Brain Barrier Transport Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Blood-Brain Barrier Transport Drugs Sales Price Analysis
  5.5.4 Japan 2016 Blood-Brain Barrier Transport Drugs Market Share Analysis
5.6 India Blood-Brain Barrier Transport Drugs Market Analysis
  5.6.1 India Blood-Brain Barrier Transport Drugs Market Overview
  5.6.2 India 2012-2017E Blood-Brain Barrier Transport Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Blood-Brain Barrier Transport Drugs Sales Price Analysis
  5.6.4 India 2016 Blood-Brain Barrier Transport Drugs Market Share Analysis

6 GLOBAL 2012-2017E BLOOD-BRAIN BARRIER TRANSPORT DRUGS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Blood-Brain Barrier Transport Drugs Sales by Type
6.2 Different Types of Blood-Brain Barrier Transport Drugs Product Interview Price Analysis
6.3 Different Types of Blood-Brain Barrier Transport Drugs Product Driving Factors Analysis
  6.3.1 Carrier-mediated Transport of Blood-Brain Barrier Transport Drugs Growth Driving Factor Analysis
  6.3.2 Receptor-mediated Transport of Blood-Brain Barrier Transport Drugs Growth Driving Factor Analysis
  6.3.3 Absorptive-mediated Transport of Blood-Brain Barrier Transport Drugs Growth Driving Factor Analysis
  6.3.4 Active Efflux Transport of Blood-Brain Barrier Transport Drugs Growth Driving Factor Analysis
  6.3.5 Others of Blood-Brain Barrier Transport Drugs Growth Driving Factor Analysis

7 GLOBAL 2012-2017E BLOOD-BRAIN BARRIER TRANSPORT DRUGS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Blood-Brain Barrier Transport Drugs Consumption by Application
7.2 Different Application of Blood-Brain Barrier Transport Drugs Product Interview Price Analysis
7.3 Different Application of Blood-Brain Barrier Transport Drugs Product Driving Factors Analysis
  7.3.1 Alzheimer's Disease of Blood-Brain Barrier Transport Drugs Growth Driving Factor Analysis
  7.3.2 Epilepsy of Blood-Brain Barrier Transport Drugs Growth Driving Factor Analysis
  7.3.3 Parkinson's Disease of Blood-Brain Barrier Transport Drugs Growth Driving Factor Analysis
  7.3.4 Multiple Sclerosis of Blood-Brain Barrier Transport Drugs Growth Driving Factor Analysis
  7.3.5 Hunter's Syndrome of Blood-Brain Barrier Transport Drugs Growth Driving Factor Analysis
  7.3.6 Brain Cancer of Blood-Brain Barrier Transport Drugs Growth Driving Factor Analysis
  7.3.7 Others of Blood-Brain Barrier Transport Drugs Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF BLOOD-BRAIN BARRIER TRANSPORT DRUGS

8.1 Cyclenium
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Cyclenium 2016 Blood-Brain Barrier Transport Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Cyclenium 2016 Blood-Brain Barrier Transport Drugs Business Region Distribution Analysis
8.2 BioAdvance
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 BioAdvance 2016 Blood-Brain Barrier Transport Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 BioAdvance 2016 Blood-Brain Barrier Transport Drugs Business Region Distribution Analysis
8.3 EIP Pharma
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 EIP Pharma 2016 Blood-Brain Barrier Transport Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 EIP Pharma 2016 Blood-Brain Barrier Transport Drugs Business Region Distribution Analysis
8.4 Bioasis
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Bioasis 2016 Blood-Brain Barrier Transport Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Bioasis 2016 Blood-Brain Barrier Transport Drugs Business Region Distribution Analysis
8.5 Immune Pharmaceuticals
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Immune Pharmaceuticals 2016 Blood-Brain Barrier Transport Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Immune Pharmaceuticals 2016 Blood-Brain Barrier Transport Drugs Business Region Distribution Analysis
8.6 AZ Therapies
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 AZ Therapies 2016 Blood-Brain Barrier Transport Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 AZ Therapies 2016 Blood-Brain Barrier Transport Drugs Business Region Distribution Analysis
8.7 Palobiofarma
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Palobiofarma 2016 Blood-Brain Barrier Transport Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Palobiofarma 2016 Blood-Brain Barrier Transport Drugs Business Region Distribution Analysis
8.8 Bach Pharma
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Bach Pharma 2016 Blood-Brain Barrier Transport Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Bach Pharma 2016 Blood-Brain Barrier Transport Drugs Business Region Distribution Analysis
8.9 BrainsGate
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 BrainsGate 2016 Blood-Brain Barrier Transport Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 BrainsGate 2016 Blood-Brain Barrier Transport Drugs Business Region Distribution Analysis
8.10 CarThera
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 CarThera 2016 Blood-Brain Barrier Transport Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 CarThera 2016 Blood-Brain Barrier Transport Drugs Business Region Distribution Analysis
8.11 Dainippon Sumitomo Pharma
8.12 Fluorinov Pharma
8.13 Fondazione Telethon
8.14 Minoryx
8.15 NewGen Therapeutics

9 DEVELOPMENT TREND OF ANALYSIS OF BLOOD-BRAIN BARRIER TRANSPORT DRUGS MARKET

9.1 Global Blood-Brain Barrier Transport Drugs Market Trend Analysis
  9.1.1 Global 2017-2022 Blood-Brain Barrier Transport Drugs Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Blood-Brain Barrier Transport Drugs Sales Price Forecast
9.2 Blood-Brain Barrier Transport Drugs Regional Market Trend
  9.2.1 North America 2017-2022 Blood-Brain Barrier Transport Drugs Consumption Forecast
  9.2.2 China 2017-2022 Blood-Brain Barrier Transport Drugs Consumption Forecast
  9.2.3 Europe 2017-2022 Blood-Brain Barrier Transport Drugs Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Blood-Brain Barrier Transport Drugs Consumption Forecast
  9.2.5 Japan 2017-2022 Blood-Brain Barrier Transport Drugs Consumption Forecast
  9.2.6 India 2017-2022 Blood-Brain Barrier Transport Drugs Consumption Forecast
9.3 Blood-Brain Barrier Transport Drugs Market Trend (Product Type)
9.4 Blood-Brain Barrier Transport Drugs Market Trend (Application)

10 BLOOD-BRAIN BARRIER TRANSPORT DRUGS MARKETING TYPE ANALYSIS

10.1 Blood-Brain Barrier Transport Drugs Regional Marketing Type Analysis
10.2 Blood-Brain Barrier Transport Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Blood-Brain Barrier Transport Drugs by Region
10.4 Blood-Brain Barrier Transport Drugs Supply Chain Analysis

11 CONSUMERS ANALYSIS OF BLOOD-BRAIN BARRIER TRANSPORT DRUGS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL BLOOD-BRAIN BARRIER TRANSPORT DRUGS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Blood-Brain Barrier Transport Drugs
Table Product Specifications of Blood-Brain Barrier Transport Drugs
Table Classification of Blood-Brain Barrier Transport Drugs
Figure Global Production Market Share of Blood-Brain Barrier Transport Drugs by Type in 2016
Figure Carrier-mediated Transport Picture
Table Major Manufacturers of Carrier-mediated Transport
Figure Receptor-mediated Transport Picture
Table Major Manufacturers of Receptor-mediated Transport
Figure Absorptive-mediated Transport Picture
Table Major Manufacturers of Absorptive-mediated Transport
Figure Active Efflux Transport Picture
Table Major Manufacturers of Active Efflux Transport
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Blood-Brain Barrier Transport Drugs
Figure Global Consumption Volume Market Share of Blood-Brain Barrier Transport Drugs by Application in 2016
Figure Alzheimer's Disease Examples
Table Major Consumers in Alzheimer's Disease
Figure Epilepsy Examples
Table Major Consumers in Epilepsy
Figure Parkinson's Disease Examples
Table Major Consumers in Parkinson's Disease
Figure Multiple Sclerosis Examples
Table Major Consumers in Multiple Sclerosis
Figure Hunter's Syndrome Examples
Table Major Consumers in Hunter's Syndrome
Figure Brain Cancer Examples
Table Major Consumers in Brain Cancer
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Blood-Brain Barrier Transport Drugs by Regions
Figure North America Blood-Brain Barrier Transport Drugs Market Size (Million USD) (2012-2022)
Figure China Blood-Brain Barrier Transport Drugs Market Size (Million USD) (2012-2022)
Figure Europe Blood-Brain Barrier Transport Drugs Market Size (Million USD) (2012-2022)
Figure Southeast Asia Blood-Brain Barrier Transport Drugs Market Size (Million USD) (2012-2022)
Figure Japan Blood-Brain Barrier Transport Drugs Market Size (Million USD) (2012-2022)
Figure India Blood-Brain Barrier Transport Drugs Market Size (Million USD) (2012-2022)
Table Blood-Brain Barrier Transport Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Blood-Brain Barrier Transport Drugs in 2016
Figure Manufacturing Process Analysis of Blood-Brain Barrier Transport Drugs
Figure Industry Chain Structure of Blood-Brain Barrier Transport Drugs
Table Capacity and Commercial Production Date of Global Blood-Brain Barrier Transport Drugs Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Blood-Brain Barrier Transport Drugs Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Blood-Brain Barrier Transport Drugs Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Blood-Brain Barrier Transport Drugs Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Blood-Brain Barrier Transport Drugs 2012-2017
Figure Global 2012-2017E Blood-Brain Barrier Transport Drugs Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Blood-Brain Barrier Transport Drugs Market Size (Value) and Growth Rate
Table 2012-2017E Global Blood-Brain Barrier Transport Drugs Capacity and Growth Rate
Table 2016 Global Blood-Brain Barrier Transport Drugs Capacity (K Pcs) List (Company Segment)
Table 2012-2017E Global Blood-Brain Barrier Transport Drugs Sales (K Pcs) and Growth Rate
Table 2016 Global Blood-Brain Barrier Transport Drugs Sales (K Pcs) List (Company Segment)
Table 2012-2017E Global Blood-Brain Barrier Transport Drugs Sales Price (USD/Pcs)
Table 2016 Global Blood-Brain Barrier Transport Drugs Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Blood-Brain Barrier Transport Drugs 2012-2017E
Figure North America 2012-2017E Blood-Brain Barrier Transport Drugs Sales Price (USD/Pcs)
Figure North America 2016 Blood-Brain Barrier Transport Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Blood-Brain Barrier Transport Drugs 2012-2017E
Figure China 2012-2017E Blood-Brain Barrier Transport Drugs Sales Price (USD/Pcs)
Figure China 2016 Blood-Brain Barrier Transport Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Blood-Brain Barrier Transport Drugs 2012-2017E
Figure Europe 2012-2017E Blood-Brain Barrier Transport Drugs Sales Price (USD/Pcs)
Figure Europe 2016 Blood-Brain Barrier Transport Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Blood-Brain Barrier Transport Drugs 2012-2017E
Figure Southeast Asia 2012-2017E Blood-Brain Barrier Transport Drugs Sales Price (USD/Pcs)
Figure Southeast Asia 2016 Blood-Brain Barrier Transport Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Blood-Brain Barrier Transport Drugs 2012-2017E
Figure Japan 2012-2017E Blood-Brain Barrier Transport Drugs Sales Price (USD/Pcs)
Figure Japan 2016 Blood-Brain Barrier Transport Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Blood-Brain Barrier Transport Drugs 2012-2017E
Figure India 2012-2017E Blood-Brain Barrier Transport Drugs Sales Price (USD/Pcs)
Figure India 2016 Blood-Brain Barrier Transport Drugs Sales Market Share
Table Global 2012-2017E Blood-Brain Barrier Transport Drugs Sales (K Pcs) by Type
Table Different Types Blood-Brain Barrier Transport Drugs Product Interview Price
Table Global 2012-2017E Blood-Brain Barrier Transport Drugs Sales (K Pcs) by Application
Table Different Application Blood-Brain Barrier Transport Drugs Product Interview Price
Table Cyclenium Information List
Table Product A Overview
Table Product B Overview
Table 2016 Cyclenium Blood-Brain Barrier Transport Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Cyclenium Blood-Brain Barrier Transport Drugs Business Region Distribution
Table BioAdvance Information List
Table Product A Overview
Table Product B Overview
Table 2016 BioAdvance Blood-Brain Barrier Transport Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 BioAdvance Blood-Brain Barrier Transport Drugs Business Region Distribution
Table EIP Pharma Information List
Table Product A Overview
Table Product B Overview
Table 2015 EIP Pharma Blood-Brain Barrier Transport Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 EIP Pharma Blood-Brain Barrier Transport Drugs Business Region Distribution
Table Bioasis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bioasis Blood-Brain Barrier Transport Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Bioasis Blood-Brain Barrier Transport Drugs Business Region Distribution
Table Immune Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Business Region Distribution
Table AZ Therapies Information List
Table Product A Overview
Table Product B Overview
Table 2016 AZ Therapies Blood-Brain Barrier Transport Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 AZ Therapies Blood-Brain Barrier Transport Drugs Business Region Distribution
Table Palobiofarma Information List
Table Product A Overview
Table Product B Overview
Table 2016 Palobiofarma Blood-Brain Barrier Transport Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Palobiofarma Blood-Brain Barrier Transport Drugs Business Region Distribution
Table Bach Pharma Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bach Pharma Blood-Brain Barrier Transport Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Bach Pharma Blood-Brain Barrier Transport Drugs Business Region Distribution
Table BrainsGate Information List
Table Product A Overview
Table Product B Overview
Table 2016 BrainsGate Blood-Brain Barrier Transport Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 BrainsGate Blood-Brain Barrier Transport Drugs Business Region Distribution
Table CarThera Information List
Table Product A Overview
Table Product B Overview
Table 2016 CarThera Blood-Brain Barrier Transport Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 CarThera Blood-Brain Barrier Transport Drugs Business Region Distribution
Table Dainippon Sumitomo Pharma Information List
Table Fluorinov Pharma Information List
Table Fondazione Telethon Information List
Table Minoryx Information List
Table NewGen Therapeutics Information List
Figure Global 2017-2022 Blood-Brain Barrier Transport Drugs Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2017-2022 Blood-Brain Barrier Transport Drugs Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Blood-Brain Barrier Transport Drugs Sales Price (USD/Pcs) Forecast
Figure North America 2017-2022 Blood-Brain Barrier Transport Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2017-2022 Blood-Brain Barrier Transport Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2017-2022 Blood-Brain Barrier Transport Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Blood-Brain Barrier Transport Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2017-2022 Blood-Brain Barrier Transport Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2017-2022 Blood-Brain Barrier Transport Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Blood-Brain Barrier Transport Drugs by Type 2017-2022
Table Global Consumption Volume (K Pcs) of Blood-Brain Barrier Transport Drugs by Application 2017-2022
Table Traders or Distributors with Contact Information of Blood-Brain Barrier Transport Drugs by Region